{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:54:18Z","timestamp":1793836458630,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clineuro.2022.107299","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T11:38:45Z","timestamp":1653997125000},"page":"107299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Edaravone for acute ischemic stroke \u2013 Systematic review with meta-analysis."],"prefix":"10.1016","volume":"219","author":[{"given":"Mariana","family":"Fidalgo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ricardo Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Viseu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Greg\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Afreixo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Greg\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2022.107299_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","author":"Johnson","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107299_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3164\/jcbn.17-62","article-title":"How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?","volume":"62","author":"Watanabe","year":"2021","journal-title":"J. Clin. Biochem Nutr."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107299_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","article-title":"Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: Randomized, placebo-controlled, double-blind study at multicenters","volume":"15","author":"Otomo","year":"2003","journal-title":"Cereb. Dis."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107299_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11845-015-1371-9","article-title":"Edaravone offers neuroprotection for acute diabetic stroke patients","volume":"185","author":"Zheng","year":"2016","journal-title":"Ir. J. Med Sci."},{"issue":"December 2017","key":"10.1016\/j.clineuro.2022.107299_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clineuro.2018.02.026","article-title":"Effects of edaravone, the free radical scavenger, on outcomes in acute cerebral infarction patients treated with ultra-early thrombolysis of recombinant tissue plasminogen activator","volume":"167","author":"Lee","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107299_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0039-1700790","article-title":"Efficacy of neuroprotective drugs in acute ischemic stroke: is it helpful?","volume":"10","author":"Mehta","year":"2019","journal-title":"J. Neurosci. Rural Pr."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107299_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0972-2327.82794","article-title":"A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke","volume":"14","author":"Sharma","year":"2011","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107299_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Abe","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2022.107299_bib9","article-title":"Edaravone for acute ischaemic stroke","volume":"12","author":"Feng","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.clineuro.2022.107299_bib10","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107299_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/STROKEAHA.118.023815","article-title":"Clinical effects of early edaravone use in acute ischemic stroke patients treated by endovascular reperfusion therapy","volume":"50","author":"Enomoto","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107299_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2169\/internalmedicine.45.1423","article-title":"Efficacy of edaravone in cardioembolic stroke","volume":"45","author":"Inatomi","year":"2006","journal-title":"Intern Med."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107299_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2176\/nmc.ra.2014-0219","article-title":"Effect of edaravone on favorable outcome in patients with acute cerebral large vessel occlusion: subanalysis of RESCUE-Japan registry","volume":"55","author":"Miyaji","year":"2015","journal-title":"Neurol. Med Chir. (Tokyo)"},{"issue":"3\u20134","key":"10.1016\/j.clineuro.2022.107299_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000488038","article-title":"Associations between uric acid level and 3-month functional outcome in acute ischemic stroke patients treated with\/without edaravone","volume":"45","author":"Naganuma","year":"2018","journal-title":"Cereb. Dis."},{"issue":"1\u20132","key":"10.1016\/j.clineuro.2022.107299_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2004.03.002","article-title":"Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion","volume":"221","author":"Toyoda","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107299_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jns.2014.07.018","article-title":"Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator","volume":"345","author":"Wada","year":"2014","journal-title":"J. Neurol. Sci. [Internet]"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107299_bib17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.011","article-title":"Edaravone with and without.6\u2009Mg\/Kg alteplase within 4.5 hours after ischemic stroke: a prospective cohort study (PROTECT4.5)","volume":"26","author":"Yamaguchi","year":"2017","journal-title":"J. Stroke Cereb. Dis.]"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107299_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2739\/kurumemedj.MS62009","article-title":"Investigation of effect of edaravone on ischemic stroke","volume":"60","author":"Ishibashi","year":"2013","journal-title":"Kurum Med. J."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107299_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000353680","article-title":"Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen","volume":"36","author":"Kaste","year":"2013","journal-title":"Cereb. Dis."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107299_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.07.016","article-title":"Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan","volume":"22","author":"Kono","year":"2013","journal-title":"J. Stroke Cereb. Dis. J. Natl. Stroke Assoc."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107299_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.02.010","article-title":"Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age","volume":"22","author":"Kono","year":"2013","journal-title":"J. Stroke Cereb. Dis. J. Natl. Stroke Assoc."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107299_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2176\/nmc.48.292","article-title":"Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism","volume":"48","author":"Mishina","year":"2008","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"issue":"7","key":"10.1016\/j.clineuro.2022.107299_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2176\/nmc.45.344","article-title":"Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction","volume":"45","author":"Mishina","year":"2005","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107299_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/17518423.2013.830153","article-title":"Edaravone for acute stroke: meta-analyses of data from randomized controlled trials","volume":"18","author":"Yang","year":"2015","journal-title":"Dev. Neurorehabil."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107299_bib25","first-page":"109","article-title":"Safety and efficacy of edaravone combined with alteplase for patients with acute ischemic stroke: a systematic review and meta-analysis","volume":"76","author":"Hu","year":"2021","journal-title":"Pharmazie"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107299_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/jcpt.13392","article-title":"Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: a meta-analysis of randomized controlled trials","volume":"46","author":"Chen","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.clineuro.2022.107299_bib27","article-title":"Race\/ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy","author":"Mehta","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2022.107299_bib28","doi-asserted-by":"crossref","unstructured":"Goyal M., Menon BK, Van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet (London, England) [Internet]. 2016 Apr 23 [cited 2021 Dec 15];387(10029):1723\u201331. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26898852\/.","DOI":"10.1016\/S0140-6736(16)00163-X"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107299_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"Nogueira","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107299_bib30","first-page":"1549","article-title":"Patient-reported outcome measures (PROMs) for acute stroke: rationale","volume":"49","author":"Reeves","year":"2021","journal-title":"Methods Future Dir. Stroke"},{"issue":"9074","key":"10.1016\/j.clineuro.2022.107299_bib31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"2021","journal-title":"Lancet (Lond., Engl.)"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107299_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ije\/31.1.115","article-title":"Direction and impact of language bias in meta-analyses of controlled trials: empirical study","volume":"31","author":"J\u00fcni","year":"2021","journal-title":"Int. J. Epidemiol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722001809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722001809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:41:37Z","timestamp":1759588897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722001809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":32,"alternative-id":["S0303846722001809"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107299","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Edaravone for acute ischemic stroke \u2013 Systematic review with meta-analysis.","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107299"}}